Bio-Rad Laboratories EPS - Earnings per Share 2010-2025 | BIO
Bio-Rad Laboratories annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Bio-Rad Laboratories EPS for the quarter ending March 31, 2025 was $2.29, a 82.97% decline year-over-year.
- Bio-Rad Laboratories EPS for the twelve months ending March 31, 2025 was $-76.52, a 615.81% increase year-over-year.
- Bio-Rad Laboratories 2024 annual EPS was $-65.36, a 199.54% increase from 2023.
- Bio-Rad Laboratories 2023 annual EPS was $-21.82, a 82.08% decline from 2022.
- Bio-Rad Laboratories 2022 annual EPS was $-121.79, a 186.48% decline from 2021.
| Bio-Rad Laboratories Annual EPS | |
|---|---|
| 2024 | $-65.36 |
| 2023 | $-21.82 |
| 2022 | $-121.79 |
| 2021 | $140.83 |
| 2020 | $126.47 |
| 2019 | $58.27 |
| 2018 | $12.10 |
| 2017 | $4.07 |
| 2016 | $0.88 |
| 2015 | $3.71 |
| 2014 | $3.05 |
| 2013 | $2.69 |
| 2012 | $5.78 |
| 2011 | $6.29 |
| 2010 | $6.59 |
| 2009 | $5.20 |
| Bio-Rad Laboratories Quarterly EPS | |
|---|---|
| 2025-03-31 | $2.29 |
| 2024-12-31 | $-25.89 |
| 2024-09-30 | $23.34 |
| 2024-06-30 | $-76.26 |
| 2024-03-31 | $13.45 |
| 2023-12-31 | $11.81 |
| 2023-09-30 | $3.64 |
| 2023-06-30 | $-39.59 |
| 2023-03-31 | $2.32 |
| 2022-12-31 | $27.24 |
| 2022-09-30 | $-5.48 |
| 2022-06-30 | $-31.05 |
| 2022-03-31 | $-112.50 |
| 2021-12-31 | $-51.83 |
| 2021-09-30 | $129.96 |
| 2021-06-30 | $30.32 |
| 2021-03-31 | $32.38 |
| 2020-12-31 | $27.96 |
| 2020-09-30 | $43.64 |
| 2020-06-30 | $32.15 |
| 2020-03-31 | $22.72 |
| 2019-12-31 | $18.35 |
| 2019-09-30 | $-8.68 |
| 2019-06-30 | $19.86 |
| 2019-03-31 | $28.74 |
| 2018-12-31 | $-27.43 |
| 2018-09-30 | $8.89 |
| 2018-06-30 | $8.87 |
| 2018-03-31 | $21.77 |
| 2017-12-31 | $2.76 |
| 2017-09-30 | $0.73 |
| 2017-06-30 | $0.17 |
| 2017-03-31 | $0.41 |
| 2016-12-31 | $-0.77 |
| 2016-09-30 | $0.62 |
| 2016-06-30 | $0.61 |
| 2016-03-31 | $0.42 |
| 2015-12-31 | $1.54 |
| 2015-09-30 | $0.59 |
| 2015-06-30 | $0.97 |
| 2015-03-31 | $0.61 |
| 2014-12-31 | $1.34 |
| 2014-09-30 | $0.39 |
| 2014-06-30 | $1.09 |
| 2014-03-31 | $0.23 |
| 2013-12-31 | $1.04 |
| 2013-09-30 | $-0.25 |
| 2013-06-30 | $1.20 |
| 2013-03-31 | $0.70 |
| 2012-12-31 | $1.51 |
| 2012-09-30 | $1.49 |
| 2012-06-30 | $1.69 |
| 2012-03-31 | $1.09 |
| 2011-12-31 | $2.11 |
| 2011-09-30 | $1.61 |
| 2011-06-30 | $1.41 |
| 2011-03-31 | $1.16 |
| 2010-12-31 | $2.41 |
| 2010-09-30 | $1.59 |
| 2010-06-30 | $1.35 |
| 2010-03-31 | $1.24 |
| 2009-12-31 | $1.35 |
| 2009-09-30 | $1.38 |
| 2009-06-30 | $1.37 |
| 2009-03-31 | $1.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.072B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.442B | 27.95 |
| Boston Scientific (BSX) | United States | $153.655B | 38.47 |
| Stryker (SYK) | United States | $150.679B | 31.51 |
| EssilorLuxottica (ESLOY) | France | $135.238B | 0.00 |
| Medtronic (MDT) | Ireland | $114.659B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.418B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.416B | 25.92 |
| ResMed (RMD) | United States | $37.840B | 28.42 |
| Agilent Technologies (A) | United States | $35.272B | 22.99 |
| GE HealthCare Technologies (GEHC) | United States | $35.028B | 16.63 |
| Terumo (TRUMY) | Japan | $24.711B | 32.10 |
| Koninklijke Philips (PHG) | Netherlands | $23.746B | 16.66 |
| Insulet (PODD) | United States | $20.930B | 82.15 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.825B | 12.09 |
| Baxter (BAX) | United States | $15.241B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.608B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.800B | 14.63 |
| Prestige Consumer Healthcare (PBH) | United States | $3.832B | 17.12 |
| Haemonetics (HAE) | United States | $3.755B | 17.10 |
| Perrigo (PRGO) | Ireland | $3.749B | 9.50 |
| Envista Holdings (NVST) | United States | $3.512B | 29.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.378B | 24.91 |
| QuidelOrtho (QDEL) | United States | $2.134B | 14.67 |
| LeMaitre Vascular (LMAT) | United States | $1.937B | 43.31 |
| AtriCure (ATRC) | United States | $1.587B | 0.00 |
| Acuren (TIC) | United States | $1.427B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.357B | 30.52 |
| AdaptHealth (AHCO) | United States | $1.275B | 12.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Neogen (NEOG) | United States | $1.211B | 15.50 |
| BioLife Solutions (BLFS) | United States | $1.087B | 0.00 |
| InMode (INMD) | Israel | $0.960B | 9.67 |
| Curaleaf Holdings (CURLF) | Canada | $0.818B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.780B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.736B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.641B | 0.00 |
| Owens & Minor (OMI) | United States | $0.640B | 5.31 |
| Evolus (EOLS) | United States | $0.627B | 0.00 |
| CeriBell (CBLL) | United States | $0.606B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.511B | 0.00 |
| Surmodics (SRDX) | United States | $0.444B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| Cresco Labs (CRLBF) | United States | $0.342B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.307B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cerus (CERS) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.264B | 78.17 |
| ZimVie (ZIMV) | United States | $0.262B | 11.90 |
| Brainsway (BWAY) | Israel | $0.239B | 63.17 |
| Biote (BTMD) | United States | $0.230B | 6.48 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.14 |
| Vireo Growth (VREOF) | United States | $0.164B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.124B | 15.25 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.91 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.098B | 0.00 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.57 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |